Does IXAZOMIB Cause Interstitial lung disease? 43 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Interstitial lung disease have been filed in association with IXAZOMIB (NINLARO). This represents 0.2% of all adverse event reports for IXAZOMIB.
43
Reports of Interstitial lung disease with IXAZOMIB
0.2%
of all IXAZOMIB reports
11
Deaths
25
Hospitalizations
How Dangerous Is Interstitial lung disease From IXAZOMIB?
Of the 43 reports, 11 (25.6%) resulted in death, 25 (58.1%) required hospitalization, and 2 (4.7%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IXAZOMIB. However, 43 reports have been filed with the FAERS database.
What Other Side Effects Does IXAZOMIB Cause?
Plasma cell myeloma (3,249)
Death (2,845)
Off label use (2,841)
Diarrhoea (2,560)
Pneumonia (1,583)
Nausea (1,568)
Fatigue (1,456)
Neuropathy peripheral (1,162)
Vomiting (977)
Thrombocytopenia (964)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which IXAZOMIB Alternatives Have Lower Interstitial lung disease Risk?
IXAZOMIB vs IXEKIZUMAB
IXAZOMIB vs JAKAFI
IXAZOMIB vs JAKAVI
IXAZOMIB vs JANUMET
IXAZOMIB vs JANUVIA